Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-14-000207

← back to feed
Filed
Nov 19, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 18, 2014 82.33M sh
Shares Diluted Q3 2014 · Sep 30, 2014 82.33M sh
Shares Diluted Q3 2014 · Sep 30, 2014 82.33M sh
Shares Diluted Q3 2014 · Sep 30, 2013 82.33M sh
Shares Diluted Q3 2014 · Sep 30, 2013 82.33M sh
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$34.16K
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$6M
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$47.15K
Stockholders Equity Q3 2014 · Sep 30, 2014 −$915.48K
Stockholders Equity Q3 2014 · Dec 31, 2013 −$819.8K
Current Liabilities Q3 2014 · Sep 30, 2014 $379.83K
Current Liabilities Q3 2014 · Dec 31, 2013 $351.34K
Total Liabilities Q3 2014 · Sep 30, 2014 $917.38K
Total Liabilities Q3 2014 · Dec 31, 2013 $828.83K
Current Assets Q3 2014 · Sep 30, 2014 $1.89K
Current Assets Q3 2014 · Dec 31, 2013 $9.03K
Total Assets Q3 2014 · Sep 30, 2014 $1.89K
Total Assets Q3 2014 · Dec 31, 2013 $9.03K
Sga Expense Q3 2014 · Sep 30, 2014 $6.49K
Sga Expense Q3 2014 · Sep 30, 2014 $21.63K
Sga Expense Q3 2014 · Sep 30, 2014 $2.69M
Sga Expense Q3 2014 · Sep 30, 2013 $14.07K
Sga Expense Q3 2014 · Sep 30, 2013 $40.49K
Rd Expense Q3 2014 · Sep 30, 2014 $1.3M
Net Income Q3 2014 · Sep 30, 2014 −$27.05K
Net Income Q3 2014 · Sep 30, 2014 −$95.68K
Net Income Q3 2014 · Sep 30, 2014 −$12.78M
Net Income Q3 2014 · Sep 30, 2013 −$34.01K
Net Income Q3 2014 · Sep 30, 2013 −$118.09K